EdgarLookup
10-Q XBRL

FORM 10-Q

Company
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed
November 14, 2022
Period of Report
September 30, 2022
Accession Number
0001437749-22-027265

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →